BSECompany Update3d ago · 24 Jul 2026, 02:35 pm
letter attached
Atul Ltd · 500027
✦ AI SummaryExpansion
Atul Ltd informs the stock exchange about a capital expenditure proposal for manufacturing facilities of Mecoprop-p (MCPP-p) and 2-methyl-4-chlorophenoxyacetic acid (MCPA) with a proposed capacity addition of 1,000 tpa and 750 tpa respectively. The investment required is ₹ 167 cr excluding working capital and goods and service tax. The proposed capacity is to be added within 67 weeks. The Board of Directors approved the proposal at their meeting held today.
Analysis Scores
Earnings Impact6/10
Growth Catalyst8/10
Governance Concern1/10
Regulatory Risk2/10
Balance Sheet Risk5/10
Liquidity Impact9/10
Market Sentiment7/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Atul Ltd - 500027 - Letter Attached
Attachments (1)
📄pdf
Download →
0b603fa3-e919-48a7-abd7-56c42eab10f9.pdf
View document text
July 24, 2026
The Manager The Manager
Listing Department Listing Department
BSE Limited National Stock Exchange of India Limited
Phiroze Jeejeebhoy Towers Exchange Plaza, C-1, Block G
Dalal Street Bandra Kurla Complex, Bandra (East)
Mumbai 400 001 Mumbai 400 051
Through: BSE Listing portal Through: NEAPS
Scrip code: 500027 Symbol: ATUL
Dear Sir:
Sub: Capital expenditure for manufacturing facility of MCPP-p and MCPA
Pursuant to Regulation 30 read with Schedule III of the Securities and Exchange Board of India
(Listing Obligations and Disclosure Requirements) Regulations, 2015 (“the Regulations”), we
inform you that the Board of Directors at their meeting held today, inter-alia, approved a capital
expenditure proposal for manufacturing facility of Mecoprop-p (MCPP-p) 1,000 tpa, 2-methyl-
4-chlorophenoxyacetic acid (MCPA) 750 tpa:
a) Existing capacity : Nil
b) Existing capacity utilization : Not applicable
c) Proposed capacity addition : a) MCPP-p 1,000 tpa
b) MCPA 750 tpa
d) Period within which the proposed : 67 weeks
capacity is to be added
e) Investment required : ₹ 167 cr excluding working capital and goods
and service tax
f) Mode of financing : Internal accruals
g) Rationale : To expand portfolio and strengthen position in
the Phenoxy herbicides and produce value-
added downstream products of o-Cresol and
The above were taken on record by the Board of Directors of the Company today from 10:15
am to 02:15 pm.
We request you to inform the members of the stock exchange accordingly.
Thank you,
Yours faithfully
For Atul Limited
Lalit Patni
Company Secretary and
Chief Compliance Officer